1. Home
  2. TWST vs AMLX Comparison

TWST vs AMLX Comparison

Compare TWST & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$46.04

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$14.42

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWST
AMLX
Founded
2013
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
TWST
AMLX
Price
$46.04
$14.42
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$47.89
$17.43
AVG Volume (30 Days)
1.4M
1.8M
Earning Date
02-02-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$391,557,000.00
N/A
Revenue This Year
$16.77
N/A
Revenue Next Year
$15.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.59
N/A
52 Week Low
$23.30
$2.60
52 Week High
$54.74
$17.49

Technical Indicators

Market Signals
Indicator
TWST
AMLX
Relative Strength Index (RSI) 69.16 52.85
Support Level $39.66 $14.04
Resistance Level $43.34 $15.79
Average True Range (ATR) 2.50 1.19
MACD 0.16 -0.06
Stochastic Oscillator 77.41 38.37

Price Performance

Historical Comparison
TWST
AMLX

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Share on Social Networks: